At a glance: Swiss anti-smoking drug hits the headlines
What’s the brand name? At this stage it’s a product being tested, rather than a brand coming to market. But Zurich-based Cytos Biotechnology thinks it will successfully treat nicotine addiction and prevent ex-smokers slipping back into their so-called ‘antisocial’ ways.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>